Analytical Data
-
Gene name
SAP1
- Application
-
Alternative Names
(ACP 1)(Aspartate protease 1)(Secreted aspartic protease 1)
-
Species
Candida albicans
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0CY26
-
Expression Region
51-391aa
-
Molecular Weight
43.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SAP1 (Signal Transducer and Activator of Transcription 1) is a critical protein involved in various cellular processes, including signaling pathways that regulate immune responses and inflammation. Research into SAP1 has gained significance due to its role in mediating the effects of cytokines, particularly in the context of chronic inflammatory diseases and autoimmune disorders. Understanding the structure and function of SAP1 is crucial for elucidating its mechanisms of action within the cell. Recent studies have focused on the protein's ability to form complexes with other signaling molecules and its influence on gene expression. The potential for SAP1 as a therapeutic target has led to increased interest in designing inhibitors or modulators that can selectively alter its activity. Advances in protein engineering and recombinant DNA technology have enabled researchers to produce SAP1 variants for functional studies and high-throughput screening. Additionally, structural biology techniques, such as X-ray crystallography and cryo-electron microscopy, allow for the detailed examination of SAP1 interactions at the molecular level. By elucidating the pathways and mechanisms involving SAP1, researchers aim to develop novel strategies for treating conditions associated with its dysregulation, offering new hope for patients suffering from inflammatory and autoimmune diseases.
